Literature DB >> 30669

Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.

P Sharon, M Ligumsky, D Rachmilewitz, U Zor.   

Abstract

Prostaglandin E2 (PGE2) level in rectal mucosa excised from 17 patients suffering from ulcerative colitis was 2-fold higher than that found in rectal mucosa of 17 normal subjects: 2.0 +/- 0.4 and 0.9 +/- 0.2 ng per mg of wet tissue, respectively. Accumulation of PGE 2 in 24-hr cultures of rectal mucosa specimens obtained from patients with ulcerative colitis was 112% higher than that observed in cultures from control subjects. Addition of sulfasalazine, sulfapyridine, and 5-aminosalicylic, acid to the culture medium of ulcerative colitis mucosa resulted in inhibition of PGE2 production by 34, 32, and 62%, respectively, compared to rectal specimens cultured in drug-free medium. These results suggest that PGE may mediate the inflammatory response in ulcerative colitis and that some of the therapeutic effect of sulfasalazine and its constituents are related to the inhibition of PGE synthesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 30669

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  130 in total

1.  Historical origins of current IBD concepts.

Authors:  J B Kirsner
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

Review 2.  Sulfasalazine. Multiplicity of action.

Authors:  T S Gaginella; R E Walsh
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

Review 3.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

4.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

5.  Effect of oral ibuprofen on formation of prostaglandins E and F by human gallbladder muscle and mucosa.

Authors:  D L Kaminski; Y Deshpande; L Thomas; J Qualy; W Blank
Journal:  Dig Dis Sci       Date:  1985-10       Impact factor: 3.199

6.  Changes in colonic tissue levels of inflammatory mediators in a guinea-pig model of immune colitis.

Authors:  A A Norris; A J Lewis; I J Zeitlin
Journal:  Agents Actions       Date:  1982-04

7.  Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.

Authors:  D Rachmilewitz; J S Stamler; D Bachwich; F Karmeli; Z Ackerman; D K Podolsky
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

8.  Inter-relationships between inflammatory mediators released from colonic mucosa in ulcerative colitis and their effects on colonic secretion.

Authors:  T D Wardle; L Hall; L A Turnberg
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

9.  Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro.

Authors:  K Hillier; P J Mason; S Pacheco; C L Smith
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

10.  Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.

Authors:  W F Stenson; E Lobos
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.